Home

Nantahala Capital Management reported a 7.52% stake in Quince Therapeutics QNCX · 4,528,302 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
7.52%
Last report
9.99% · filed 25/11/14
Shares held
4,528,302 sh
Class
Common Stock, par value $0.001 per share
Event date
26/03/31
Filed
26/05/15

7.52% stake · −2.5pp from the last report

Stake
7.52%
Last report
9.99%
Since last report
−2.5pp

Quince Therapeutics trades, last 26 weeks

What else happened in Quince Therapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Nantahala Capital Management's other 5% stake reports